DSM-Firmenich stock pre-market at EUR 98.17: minus 0.13 percent
Published on 09/30/2026 at 08:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
DSM-Firmenich stock was at EUR 98.17 in pre-market trading at 8:45 a.m. CEST on September 30, 2026, according to Lang & Schwarz. The price was down EUR 0.13, or minus 0.13 percent, versus the Lang & Schwarz prior close of EUR 98.30 on September 29, 2026.
Share repurchases reported
In a September 29, 2026 release, DSM-Firmenich said 313,835 ordinary shares were repurchased from September 21 through September 25 at an average price of EUR 96.45 per share, for a total of EUR 30.3 million. The company said 6,976,047 shares had been repurchased under the program to date, representing total consideration of EUR 520.9 million.
Biond portfolio launched
Also on September 29, 2026, dsm-firmenich announced Biond, a portfolio of pharmaceutical-grade vitamins for biopharmaceutical applications. The offering is available globally through Brenntag Pharma's BYPHAR portfolio, and it is scheduled to debut at CPHI Milan from October 6 through October 8, 2026.
